Thus, this study sought to determine the relationship between high expression of HBx and CD68+ TAMs infiltration in HBV-related HCC tumor tissues, and further evaluated the prognostic value of integrating HBx and CD68 for survival prediction in a cohort of HCC patients with chronic HBV infection. The gene discussed is CD68; the disease is hepatocellular carcinoma.